Korean J Urol Oncol.  2015 Apr;13(1):1-10. 10.0000/kjuo.2015.13.1.1.

Predicting Recurrence and Progession of Non Muscle Invasive Urothelial Cell Carcinoma of Bladder by Clinical and Pathological Prognostic Factors

• Choi SY
• Chang IH

• KMID: 2307827
• DOI: http://doi.org/10.0000/kjuo.2015.13.1.1

Abstract

About 80% of Bladder cancer is non muscle invasive bladder cancer (NMIBC). Despite of appropriate therapy, a lot of NMIBC recur as a superficial tumor or progress to muscle invasive disease. Several studies about prognostic factors of recurrence and progression have reported a single risk factor variously according to each study. These efforts were developed to predict the risk by scoring system and large-scale studies had been conducted. These studies had limitations that their patients did not receive BCG (bacillus Calmette-Guerin) immunotherapy, immediate intravesical chemotherapy, second-look TUR (transurethral resection) in high-risk group. Through studies to date, patients with NMIBC have showed heterogenous prognosis and a more sophisticated scoring system can give personalized treatment and exact prediction.

Keyword

Urinary bladder neoplasms; Risk factors; Prognosis; Scoring method

MeSH Terms

Drug Therapy
Humans
Immunotherapy
Mycobacterium bovis
Prognosis
Recurrence*
Research Design
Risk Factors
Urinary Bladder Neoplasms
Urinary Bladder*